A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis
Clinical trial NCT00833768 · TERMINATED
Trial details
- NCT number
- NCT00833768
- Sponsor
- Genzyme, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2009-09-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.